Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells

Oncogene

Volumn 31, Issue 8, 2012, Pages 954-965

  Fleisig, H B ^a   Wong, J M Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cell cycle; growth kinetics; telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

CELL ADHESION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; G2 PHASE; GENE EXPRESSION; HUMANS; KINETICS; MITOSIS; RECOMBINANT PROTEINS; RNA; TELOMERASE;

EID: 84857374146     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.292     Document Type: Article

References (52)

1. Armbruster BN, Banik SS, Guo C, Smith AC, Counter CM. (2001). N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol Cell Biol 21: 7775-7786. (Pubitemid 32988786)
2. Armbruster BN, Linardic CM, Veldman T, Bansal NP, Downie DL, Counter CM. (2004). Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1. Mol Cell Biol 24: 3552-3561. (Pubitemid 38452093)
3. Banik SSR, Guo C, Smith AC, Margolis SS, Richardson DA, Tirado CA et al. (2002). C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity. Mol Cell Biol 22: 6234-6246. (Pubitemid 34857842)
4. Blasco MA. (2002). Telomerase beyond telomeres. Nat Rev Cancer 2: 627-633.
5. Blasco MA. (2005). Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6: 611-622. (Pubitemid 41044298)
6. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB et al. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352. (Pubitemid 28063364)
7. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274. (Pubitemid 27508830)
8. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248.
9. Cerone MA, Londono-Vallejo JA, Bacchetti S. (2001). Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet 10: 1945-1952. (Pubitemid 32910539)
10. Chang S, DePinho RA. (2002). Telomerase extracurricular activities. Proc Natl Acad Sci USA 99: 12520-12522.
11. Chen W, Hahn WC. (2003). SV40 early region oncoproteins and human cell transformation. Histol Histopathol 18: 541-550. (Pubitemid 36362072)
12. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. (2004). Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5: 127-136. (Pubitemid 38283799)
13. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W et al. (2008). TERT promotes epithelial proliferation through transcriptional control of a Myc-and Wnt-related developmental program. PLoS Genet 4: e10.
14. Dong CK, Masutomi K, Hahn WC. (2005). Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol 54: 85-93. (Pubitemid 40552830)
15. Etheridge KT, Banik SS, Armbruster BN, Zhu Y, Terns RM, Terns MP et al. (2002). The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277: 24764-24770. (Pubitemid 34952008)
16. Fakhoury J, Marie-Egyptienne DT, Londono-Vallejo JA, Autexier C. (2010). Telomeric function of mammalian telomerases at short telomeres. J Cell Sci 123: 1693-1704.
17. Fasching CL, Bower K, Reddel RR. (2005). Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Cancer Res 65: 2722-2729. (Pubitemid 40490073)
18. Frisch SM, Screaton RA. (2001). Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562. (Pubitemid 32817013)
19. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM et al. (2000). Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192: 1625-1636.
20. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. (1999a). Creation of human tumour cells with defined genetic elements. Nature 400: 464-468. (Pubitemid 29361801)
21. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A et al. (1999b). Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5: 1164-1170. (Pubitemid 29474421)
22. Harley CB. (2002). Telomerase is not an oncogene. Oncogene 21: 494-502. (Pubitemid 34146249)
23. Horbinski C, Mojesky C, Kyprianou N. (2010). Live free or die: tales of homeless (cells) in cancer. Am J Pathol 177: 1044-1052.
24. Huard S, Autexier C. (2004). Human telomerase catalyzes nucleolytic primer cleavage. Nucleic Acids Res 32: 2171-2180. (Pubitemid 38854772)
25. Hurlin PJ, Fry DG, Maher VM, McCormick JJ. (1987). Morphological transformation, focus formation and anchorage independence induced in diploid human fibroblasts by expression of a transfected H-ras oncogene. Cancer Res 47: 5752-5757. (Pubitemid 18046776)
26. Janknecht R. (2004). On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 564: 9-13. (Pubitemid 38490693)
27. Jha KK, Banga S, Palejwala V, Ozer HL. (1998). SV40-Mediated immortalization. Exp Cell Res 245: 1-7. (Pubitemid 28551049)
28. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88. (Pubitemid 28520454)
29. Lee SR, Wong JM, Collins K. (2003). Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate. J Biol Chem 278: 52531-52536. (Pubitemid 38035848)
30. Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, Sedivy JM et al. (2003). Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res 63: 1743-1747. (Pubitemid 36460830)
31. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB et al. (2005). The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 102: 8222-8227. (Pubitemid 40800070)
32. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB et al. (2003). Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253. (Pubitemid 36936917)
33. Morin GB. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529. (Pubitemid 19284465)
34. Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS. (2011). The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer 128: 743-752.
35. Nakamura M, Masutomi K, Kyo S, Hashimoto M, Maida Y, Kanaya T et al. (2005). Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther 16: 859-868. (Pubitemid 40982334)
36. O'Hayer KM, Counter CM. (2006). A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol 407: 637-647. (Pubitemid 43815982)
37. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. (1993). Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol 13: 6036-6043. (Pubitemid 23292598)
38. Oulton R, Harrington L. (2004). A human telomerase-associated nuclease. Mol Biol Cell 15: 3244-3256. (Pubitemid 38850120)
39. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M et al. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460: 66-72.
40. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V et al. (2003). hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22: 131-146. (Pubitemid 36152891)
41. Shay JW, Bacchetti S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
42. Smith LL, Coller HA, Roberts JM. (2003). Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5: 474-479. (Pubitemid 36592272)
43. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P et al. (2002). Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99: 12606-12611.
44. Tamakawa RA, Fleisig HB, Wong JM. (2010). Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle specific manner. Cancer Res 70: 8684-8694.
45. Tokutake Y, Matsumoto T, Watanabe T, Maeda S, Tahara H, Sakamoto S et al. (1998). Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem Biophys Res Commun 247: 765-772. (Pubitemid 28418466)
46. Verdun RE, Crabbe L, Haggblom C, Karlseder J. (2005). Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell 20: 551-561. (Pubitemid 41668640)
47. Verdun RE, Karlseder J. (2006). The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127: 709-720. (Pubitemid 44716251)
48. Wang RC, Smogorzewska A, de Lange T. (2004). Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119: 355-368. (Pubitemid 39423838)
49. Wong JM, Collins K. (2003). Telomere maintenance and disease. Lancet 362: 983-988. (Pubitemid 37159296)
50. Wong JM, Kusdra L, Collins K. (2002). Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4: 731-736. (Pubitemid 34993712)
51. Wong JMY, Collins K. (2006). Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 20: 2848-2858. (Pubitemid 44771746)
52. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C et al. (2000). Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26: 85-88.